메뉴 건너뛰기





Volumn 7, Issue 7, 1998, Pages 1063-1086

Changing therapeutic paradigms in glaucoma management

Author keywords

Alphagan ; Apoptosis; Azopt ; Beta blockers; Betaxolol; Betoptic ; Brimonidine; Brinzolamide; Cosopt ; Dorzolamide; Excitotoxicity; Genetics; Glaucoma; Glutamate; Latanoprost; Lipids(TM); Memantine; Neuroprotection; Normal tension glaucoma; Ocular bloodflow; Ocular hypertension; Ocular Hypotensive; Optic neuropathy; Timolol; Timoptic ; Trusopt ; Xalaton

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; BERTAGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNOPROSTONE ISOPROPYL ESTER;

EID: 0031926628     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.7.1063     Document Type: Review
Times cited : (34)

References (214)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.